Public Profile

Western Drugs Ltd

Western Drugs Ltd., headquartered in India, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality generic and branded medications. Established in 1985, the company has achieved significant milestones, including regulatory approvals and partnerships that have expanded its operational reach across various regions, including Asia, Europe, and North America. With a diverse portfolio that includes formulations for chronic and acute conditions, Western Drugs Ltd. is recognised for its commitment to quality and innovation. The company’s state-of-the-art manufacturing facilities adhere to stringent international standards, ensuring the delivery of safe and effective products. As a trusted name in pharmaceuticals, Western Drugs Ltd. continues to strengthen its market position through a focus on research and development, contributing to improved healthcare outcomes globally.

DitchCarbon Score

How does Western Drugs Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Western Drugs Ltd's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

1%

Western Drugs Ltd's reported carbon emissions

Western Drugs Ltd, headquartered in India, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions data, it is essential to highlight that Western Drugs Ltd has not outlined any specific reduction targets or commitments to climate initiatives. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed its commitments. As the pharmaceutical industry increasingly prioritises sustainability, Western Drugs Ltd may benefit from establishing clear climate commitments and reduction targets to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Western Drugs Ltd's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Western Drugs Ltd is headquartered in IN, which has a rank of very high, indicating very high grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Western Drugs Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

BERNARD

VN
Health Services
Updated 11 days ago

Leafcon Agro

IN
Health Services
Updated 11 days ago

Akuratemp

US
Health Services
Updated 11 days ago

Jabra Enhance

US
Health Services
Updated 2 days ago

KOLLUND A/S

DK
Health Services
Updated 11 days ago

SSW

JP
Health Services
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers